Glass specialist Schott Pharma touts 2023 sales growth, Serbia expansion and hiring plans
Fierce Pharma
DECEMBER 20, 2023
Following an IPO and ahead of its fiscal 2023 earnings release next month, German drug containment and delivery specialist Schott Pharma is trumpeting its recent momentum. | Following an IPO and ahead of its fiscal 2023 earnings release next month, pharma glass specialist Schott Pharma is trumpeting its recent momentum.
Let's personalize your content